Alopecia Areata
8 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Baricitinib for alopecia areata | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Deuruxolitinib for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo - 100 mg + Ritlecitinib 50 mg for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo - 50 mg + Ritlecitinib 100 mg for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo + Upadacitinib for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ritlecitinib 100 mg for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Upadacitinib for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |